RETRACTION: Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma) (Retraction of Vol 23, Pg 1947, 2017)

被引：1
|
作者：
Song, Hao
Chi, Yuchun
Shi, Chunling
Xu, Miao
Yu, Benxia
Zhang, Zhongsheng
机构：
来源：
MEDICAL SCIENCE MONITOR | 2018年 / 24卷
关键词：
D O I：
10.12659/MSM.912715
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：5904 / 5904
页数：1
相关论文
共 37 条
  • [31] RETRACTION: Wnt5A regulates the expression of ROR2 tyrosine kinase receptor in ovarian cancer cells (Retraction of Vol 95, Pg 609, 2017)
    不详
    [J]. BIOCHEMISTRY AND CELL BIOLOGY, 2023, 101 (03) : 268 - 268
  • [32] The tuberin (TSC2), autosomal dominant polycystic kidney disease (PKD1), and somatostatin type V receptor (SSTR5) genes form a synteny group in the Fugu genome
    Sandford, R
    Sgotto, B
    Burn, T
    Brenner, S
    [J]. GENOMICS, 1996, 38 (01) : 84 - 86
  • [33] EXPRESSION OF MESSENGER-RNA FOR SOMATOSTATIN RECEPTOR (SSTR) TYPE-2 AND TYPE-5 IN INDIVIDUAL, RAT PITUITARY-CELLS - A DOUBLE-LABELING IN-SITU HYBRIDIZATION ANALYSIS
    DAY, R
    DONG, WJ
    PANETTA, R
    KRAICER, J
    GREENWOOD, MT
    PATEL, YC
    [J]. ENDOCRINOLOGY, 1995, 136 (11) : 5232 - 5235
  • [34] Discovery of novel 5-oxa-2,6-diazaspiro[3.4]oct-6-ene derivatives as potent, selective, and orally available somatostatin receptor subtype 5 (SSTR5) antagonists for treatment of type 2 diabetes mellitus
    Hirose, Hideki
    Yamasaki, Takeshi
    Ogino, Masaki
    Mizojiri, Ryo
    Tamura-Okano, Yumiko
    Yashiro, Hiroaki
    Muraki, Yo
    Nakano, Yoshihide
    Sugama, Jun
    Hata, Akito
    Iwasaki, Shinji
    Watanabe, Masanori
    Maekawa, Tsuyoshi
    Kasai, Shizuo
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (15) : 4175 - 4193
  • [35] Combination of 5-Fluorouracil (5-FU) with DNMTs or HDACs as Epigenetic Modifiers Has Synergistic Effects on Radiosensitization and Somatostatin Receptor sstr 2 Expression in Human Neuroendocrine Tumor Cells
    Jin, X. F.
    Auernhammer, C. J.
    Ilhan, H.
    Lindner, S.
    Noelting, S.
    Maurer, J.
    Spoettl, G.
    Orth, M.
    [J]. NEUROENDOCRINOLOGY, 2019, 108 : 8 - 8
  • [36] Discovery of novel 5-oxa-2,6-diazaspiro[3.4]oct-6-ene derivatives as potent, selective, and orally available somatostatin receptor subtype 5 (SSTR5) antagonists for treatment of type 2 diabetes mellitus
    Hirose, Hideki
    Yamasaki, Takeshi
    Yamashita, Tohru
    Ogino, Masaki
    Mizojiri, Ryo
    Takakura, Nobuyuki
    Morimoto, Sachie
    Nakahata, Takashi
    Kina, Asato
    Tamura, Yumiko
    Surma, Jun
    Yashiro, Hiroaki
    Muraki, Yo
    Nakano, Yoshihide
    Hata, Akito
    Odani, Tomoyuki
    Shimizu, Yuji
    Iwasaki, Shinji
    Watanabe, Masanori
    Maekawa, Tsuyoshi
    Kasai, Shizuo
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [37] RETRACTION: Curcumin Exerts Effects on the Pathophysiology of Alzheimer's Disease by Regulating PI(3,5)P2 and Transient Receptor Potential Mucolipin-1 Expression (Retraction of Vol 8, art no 531, 2017)
    [J]. FRONTIERS IN NEUROLOGY, 2019, 10
1234